Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome
Md. Eisner et al., Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome, AM J R CRIT, 164(2), 2001, pp. 231-236
In patients with acute lung injury (ALI) and acute respiratory distress syn
drome (ARDS), a recent ARDS Network randomized controlled trial demonstrate
d that a low tidal volume (VT) mechanical ventilation strategy (6 ml/kg) re
duced mortality by 22% compared with traditional mechanical ventilation (12
ml/kg). In this study, we examined the relative efficacy Of low VT mechani
cal ventilation among 902 patients with different clinical risk factors for
AWARDS who participated in ARDS Network randomized controlled trials. The
clinical risk factor for ALI/ARDS was associated with substantial variation
in mortality. The risk of death (before discharge home with unassisted bre
athing) was highest in patients with sepsis (43%); intermediate in subjects
with pneumonia (36%), aspiration (37%), and other risk factors (35%); and
lowest in those with trauma (11%) (p < 0.0001). Despite these differences i
n mortality, there was no evidence that the efficacy of the low VT strategy
varied by clinical risk factor (p = 0.76, for interaction between ventilat
or group and risk factor). There was also no evidence of differential effic
acy Of low VT ventilation in the other study outcomes: proportion of patien
ts achieving unassisted breathing (p = 0.59), ventilator-free days (p = 0.5
8), or development of nonpulmonary organ failure (p = 0.44). Controlling fo
r demographic and clinical covariates did not appreciably affect these resu
lts. After reclassifying the clinical risk factors as pulmonary versus nonp
ulmonary predisposing conditions and infection-related versus non-infection
-related conditions, there was still no evidence that the efficacy Of low V
T ventilation differed among clinical risk factor subgroups. In conclusion,
we found no evidence that the efficacy of the low VT ventilation strategy
differed among clinical risk factor subgroups for ALI/ARDS.